
    
      As specified by Phase 1 protocol-flexible language in the protocol, modifications to the dose
      or dosing regimen can be made to achieve the scientific goals of the study objectives and/or
      to ensure appropriate safety of the study participants. The proposed doses for each Panel may
      be adjusted downward based on evaluation of observed safety, tolerability, and PK data.
    
  